UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended December 31, 2022 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission File Number: 000-23329 Charles & Colvard, Ltd. (Exact name of registrant as specified in its charter) North Carolina 56-1928817 ...

Charles & Colvard, Ltd. (NASDAQ:CTHR) Q1 2023 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Don O'Connell - President & Chief Executive Officer Clint Pete - Chief Financial Officer Conference Call Participants Operator Good day and welcome to the Charles & Colvard First Quarter Fiscal 2023 Results Conference Call and webcast. Our participants will be in a listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator ...

Q1 FY 2023 Earnings C O N F E R E N C E C A L L P R E S E N T A T I O N Nasdaq: CTHR Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from ____ ...

Financial Data and Key Metrics Changes - The company reported Q4 fiscal 2022 revenue of $9.3 million, a decrease of 4% compared to the previous year, but achieved a record annual revenue of $43.1 million, representing a 10% increase year-over-year [3][7][9] - Gross profit for the fiscal year was $20.2 million, up from $18.4 million last year, with a gross margin of 41% for Q4, down from 45% in the prior year [5][10] - The company maintained a strong cash position of $21.2 million and zero debt, with working capital at $29.1 million [5][13] Business Line Data and Key Metrics Changes - Revenue from the online channels segment increased by 15% to $26.8 million, representing 62% of total net sales for the fiscal year [9] - Finished jewelry net sales increased by 22% to $29.7 million, while loose jewels net sales decreased by 22% due to reduced demand from distributors [9][11] - Moissanite revenue grew by 13% year-over-year, while lab-grown diamond sales surged by 173% year-over-year [4][11] Market Data and Key Metrics Changes - International net sales increased by 12%, while cross-border trade sales on the transactional website remained steady compared to the previous year [9] - The traditional segment, which includes wholesale and brick-and-mortar customers, saw a 14% decrease in sales, indicating challenges in the retail environment [8][30] Company Strategy and Development Direction - The company is focusing on increasing brand awareness and positioning its lab-grown diamond products, with a strategic investment in marketing and digital engagement [15][16] - Plans include expanding product assortments and enhancing direct-to-consumer initiatives, particularly in the lab-grown diamond space [18][23] - The company aims to differentiate itself in the competitive lab-grown diamond market and is exploring vertical acquisitions to grow its footprint [36][37] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the impact of inflation and economic uncertainty on consumer behavior but emphasized the importance of maintaining brand visibility and investment in growth initiatives [20][19] - The company is optimistic about its positioning in the lab-grown diamond market and believes there is significant growth potential despite competitive pressures [36][37] Other Important Information - The company has successfully launched a digital production studio to enhance marketing capabilities and engage with consumers through live streaming and shopping events [21][33] - The Signature showroom is set to open soon, which is expected to contribute to revenue growth [45][46] Q&A Session Summary Question: What caused the drop in gross margins? - Management explained that the drop in gross margins was due to inventory management strategies and pricing pressures in the lab-grown diamond market, but they remain confident in future margin recovery [24][25][26] Question: How are lab-grown products performing compared to moissanite? - The average order value (AOV) remains strong, with lab-grown diamonds showing significant growth, while moissanite sales also increased [27][28] Question: What is the outlook for traditional channels? - Management noted that the traditional segment is facing challenges but remains a consistent revenue source, with growth expected from direct-to-consumer channels [30][31] Question: Will there be a slowdown in investment as fixed costs stabilize? - Management indicated that while some investments are fixed, ongoing marketing and co-op advertising will continue to be driven by revenue growth [38][39] Question: How is the company managing inventory amid economic headwinds? - The company maintains confidence in its inventory composition and is prepared for the holiday season, emphasizing the intrinsic value of finished jewelry [40][41] Question: What caused the delay in the Signature showroom opening? - Delays were attributed to supply chain constraints and local municipality inspections, but costs have remained within budget [44][46] Question: Is the company actively reducing loose jewel sales? - Management confirmed a strategic shift towards finished jewelry sales, reducing loose jewel inventory in line with consumer demand [47]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2022 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-23329 Charles & Colvard, Ltd. (Exact name of registrant as specified in its charter) North Carolina 56-1928817 (State or other jurisdict ...

| --- | --- | --- | --- | --- | |-------------------------------------------------------------------------|-------|-------|-------|------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Q3 FY 2022 Earnings C O N F E R E N C E C A L L P R E S E N T A T I O N | | | | the first of the | Nasdaq: CTHR Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securi ...

Charles & Colvard, Ltd. (NASDAQ:CTHR) Q3 2022 Earnings Conference Call May 5, 2022 8:00 AM ET Company Participants Don O'Connell - President and CEO Clint Pete - CFO Conference Call Participants Jason Ursaner - Bumbershoot Holdings Paul Zimnisky - PZDA Michael Zabran - ROTH Capital Operator Good morning. This earnings call may contain forward-looking statements as defined in Section 27A of the Securities Act of 1933 as amended, including statements regarding, among other things, the company's business strat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2022 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ t ...

Nasdaq: CTHR Q2 FY 2022 Earnings Conference Call Presentation FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act o ...